Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.13T
Market cap1.13T
Price-Earnings ratio
43.70
Price-Earnings ratio43.70
Dividend yield
0.53%
Dividend yield0.53%
Average volume
3.55M
Average volume3.55M
High today
$1,229.23
High today$1,229.23
Low today
$1,216.00
Low today$1,216.00
Open price
$1,208.00
Open price$1,208.00
Volume
26.00K
Volume26.00K
52 Week high
$1,238.00
52 Week high$1,238.00
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,229.23. The company's market cap stands at 1.13T, with a P/E ratio of 43.70 and a dividend yield of 0.53%.

During the trading session on 2026-07-07, Eli Lilly(LLY) shares reached a daily high of $1,229.23 and a low of $1,216.00. At a current price of $1,229.23, the stock is +1.1% higher than the low and still 0.0% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 26K, versus its average volume of 3.55M.

The stock's 52-week range extends from a low of $623.78 to a high of $1,238.00.

The stock's 52-week range extends from a low of $623.78 to a high of $1,238.00.

LLY News

Nasdaq 42m
Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.

Key Points The obesity drug industry is likely a decade-long tailwind for Eli Lilly's business. Foundayo and Retatrutide could cement a decade of growth. The...

Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.
TipRanks 2h
Eli Lilly Price Target Raised to $1,400 on Incretin Leadership, Obesity Growth, and Robust 2026 Outlook - TipRanks

...

Eli Lilly Price Target Raised to $1,400 on Incretin Leadership, Obesity Growth, and Robust 2026 Outlook - TipRanks
TipRanks 2h
Transcenta Returns Two Lilly-Licensed Compounds in US$4 Million Deal, Retains Blosozumab Rights

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

More LLY News

TipRanks 2h
Eli Lilly price target raised to $1,400 from $1,300 at JPMorgan

JPMorgan raised the firm’s price target on Eli Lilly (LLY) to $1,400 from $1,300 and keeps an Overweight rating on the shares. The firm sees potential upside fo...

Zacks 3h
The Zacks Analyst Blog Highlights Eli Lilly, HSBC, Palantir and CBL & Associates

This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herei...

The Zacks Analyst Blog Highlights Eli Lilly, HSBC, Palantir and CBL & Associates
Simply Wall St 7h
Eli Lilly Could Be 19% Undervalued Following Medicare GLP 1 Expansion

The latest move in Eli Lilly (LLY) stock comes as the Medicare GLP-1 Bridge program opens wider access to its weight management drugs, alongside strong reported...

Eli Lilly Could Be 19% Undervalued Following Medicare GLP 1 Expansion
Nasdaq 20h
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Key Points Eli Lilly and dominance in weight loss and diabetes treatments continues to fuel massive revenue growth. Teva Pharmaceutical Industries offers a va...

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
Nasdaq 1d
Could Buying Eli Lilly Stock Today Set You Up for Life? (Hint: Yes.)

Key Points Eli Lilly is the leader in the GLP-1 drug market. This leadership has supercharged earnings growth and stock performance in recent years. 10 stock...

Could Buying Eli Lilly Stock Today Set You Up for Life? (Hint: Yes.)
Nasdaq 1d
DKSH Signs Distribution And Promotion Agreement With Eli Lilly And Co In Hong Kong, Macau

(RTTNews) - DKSH Holding AG (DKSH.SW, DKSH), a Swiss market expansion services provider, on Monday has entered into a distribution and promotion agreement with...

DKSH Signs Distribution And Promotion Agreement With Eli Lilly And Co In Hong Kong, Macau
Simply Wall St 2d
Should Expanded Medicare GLP‑1 Access and New Oncology Wins Require Action From Eli Lilly Investors?

In late June 2026, Eli Lilly reported strong Q1 results, advanced its obesity and diabetes franchise with Medicare’s GLP‑1 Bridge program, and gained a positive...

Should Expanded Medicare GLP‑1 Access and New Oncology Wins Require Action From Eli Lilly Investors?

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.